|
2022
|
Invention
|
Derivatisation of insulin with polysaccharides.
The present invention relates to a composition c... |
|
2021
|
Invention
|
Methods of treating multiple myeloma cancers expressing high levels of epo-receptor using psa-epo... |
|
|
Invention
|
Methods of treating diseases related to net formation with parenteral administration of polysialy... |
|
2019
|
Invention
|
Glycopolysialylation of blinatumomab.
A composition comprising a population of polysaccharide-bl... |
|
|
Invention
|
Glycopolysialylation of blinatumomab. A composition comprising a population of polysaccharide-bli... |
|
2017
|
Invention
|
Fractionation of charged polysaccharide. Polydisperse and charged polysaccharides are fractionate... |
|
|
Invention
|
N-terminal polysialylation.
The present invention relates to a composition comprising a populati... |
|
|
Invention
|
Glycopolysialylation of non-blood coagulation proteins. A water soluble polymer, in particular po... |
|
|
Invention
|
Method for treatment of primary hormone resistant endometrial and breast cancers.
The invention ... |
|
|
Invention
|
Method for treatment of primary hormone resistant endometrial and breast cancers. The invention p... |
|
|
Invention
|
Derivatisation of erythropoietin (epo).
The present invention relates to a compound which is a p... |
|
2016
|
Invention
|
N-terminal derivatisation of proteins with polysaccharides. The present invention relates to meth... |
|
|
Invention
|
Method to enhance an immune response of nucleic acid vaccination.
A composition comprising lipos... |
|
|
Invention
|
Derivatisation of granulocyte colony-stimulating factor.
The present invention relates to a comp... |
|
|
Invention
|
Sialic acid derivatives for protein derivatisation and conjugation. Derivatives are synthesized o... |
|
|
Invention
|
Derivatisation of erythropoietin (epo). The present invention relates to a compound which is a po... |
|
2015
|
Invention
|
Activated sialic acid derivatives for protein derivatisation and conjugation. Derivatives of PSAs... |
|
|
Invention
|
Reduction of endotoxin in polysialic acids. The present invention relates to process for reducing... |
|
|
Invention
|
Small interfering rna delivery.
A liposomal siRNA composition is described. The liposomes are fo... |
|
|
Invention
|
Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition... |
|
|
Invention
|
Polysialic acid derivatives. A polysialic acid compound is reacted with a hetero-bifunctional rea... |
|
|
Invention
|
Derivatisation of granulocyte colony-stimulating factor. The present invention relates to a compo... |
|
|
G/S
|
Pharmaceutical and therapeutic preparations for the development of and use in therapeutics for th... |
|
2014
|
Invention
|
Method to enhance an immune response of nucleic acid vaccination. A composition comprising liposo... |
|
|
Invention
|
Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant. Neisse... |
|
|
Invention
|
Sialic acid derivatives. An amine or hydrazide derivative of a sialic acid unit, e.g. in a polysa... |
|
2003
|
G/S
|
Chemical products used in industry and science. Pharmaceutical and therapeutic preparations; drug... |
|
2001
|
G/S
|
Delivery systems for therapeutic agents based on polysialic acid derivatives of drugs, proteins, ... |
